{
    "2020-06-05": [
        [
            {
                "time": "",
                "original_text": "医药生物行业6月投资策略：后疫情时代 把握恢复性子行业和医药“新基建”增量赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "后疫情时代",
                        "恢复性子行业",
                        "新基建",
                        "增量赛道"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "云南白药 疯狂派现背后的白马股魔咒",
                "features": {
                    "keywords": [
                        "云南白药",
                        "派现",
                        "白马股",
                        "魔咒"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}